Zoetis Inc - Class A

NEW
CHIX:ZOEd (USA)   Class A
€ 66.44 (0%) Jun 30
11.92
P/B:
9.34
Market Cap:
€ 26.45B ($ 30.14B)
Enterprise V:
€ 32.86B ($ 37.44B)
Volume:
0
Avg Vol (2M):
17.00
Trade In:

Business Description

Description
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Name Current Vs Industry Vs History
Cash-To-Debt
0.21
Equity-to-Asset
0.21
Debt-to-Equity
2.86
Debt-to-EBITDA
2.3
Interest Coverage
15.53
Piotroski F-Score
8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
4.57
Distress
Grey
Safe
Beneish M-Score
-2.47
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
3.15
Quick Ratio
1.91
Cash Ratio
0.94
Days Inventory
333.03
Days Sales Outstanding
57.87
Days Payable
63.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Dividend Growth Rate
15.4
Forward Dividend Yield %
2.75
3-Year Average Share Buyback Ratio
2.9
Shareholder Yield %
9.55

Financials (Next Earnings Date:2026-08-06)

CHIX:ZOEd's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Zoetis Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 8,172.748
EPS (TTM) (€) 5.183
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI -
14-Day ATR (€) 0.376441
20-Day SMA (€) 66.44
12-1 Month Momentum % -
52-Week Range (€) 66.44 - 97
Shares Outstanding (Mil) 419.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Zoetis Inc Filings

Filing Date Document Date Form
No Filing Data

Zoetis Inc Stock Events

Financials Calendars
Event Date Price (€)
Third quarter earnings conference call for 2026 2026-11-04 08:30 In 127 days
Third quarter earnings results for 2026 2026-11-04 In 126 days
Second quarter earnings conference call for 2026 2026-08-06 08:30 In 37 days
Second quarter earnings results for 2026 2026-08-06 In 36 days
USD 0.530000 Cash Dividend 2026-07-20 In 19 days
William Blair 46th Annual Growth Stock Conference 2026-06-02 13:20 66.44 (+0.00%)
Guidance call for 2026 2026-05-28 15:00 69.04 (+0.00%)
General meeting for 2026 2026-05-20 08:00 97.00 (+0.00%)
First quarter earnings conference call for 2026 2026-05-07 08:30 97.00 (+0.00%)
First quarter earnings results for 2026 2026-05-07 97.00 (+0.00%)
Show
Entries

Zoetis Inc Frequently Asked Questions

What is Zoetis Inc(CHIX:ZOEd)'s stock price today?
The current price of CHIX:ZOEd is €66.44. The 52 week high of CHIX:ZOEd is €97.00 and 52 week low is €66.44.
When is next earnings date of Zoetis Inc(CHIX:ZOEd)?
The next earnings date of Zoetis Inc(CHIX:ZOEd) is 2026-08-06.
Does Zoetis Inc(CHIX:ZOEd) pay dividends? If so, how much?
Zoetis Inc(CHIX:ZOEd) does not pay dividend.

Articles on Zoetis Inc

No articles.